FTAC Emerald [FLD] vs Morgan Stanley [MS] Detailed Stock Comparison
FTAC Emerald
NASDAQ
Loading...
Morgan Stanley
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: FTAC Emerald wins in 5 metrics, Morgan Stanley wins in 11 metrics, with 0 ties. Morgan Stanley appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | FTAC Emerald | Morgan Stanley | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 218.80 | 16.40 | Morgan Stanley |
| Price-to-Book Ratio | 1.94 | 2.35 | FTAC Emerald |
| Debt-to-Equity Ratio | 90.30 | 438.54 | FTAC Emerald |
| PEG Ratio | -0.14 | 1.01 | FTAC Emerald |
| EV/EBITDA | -13.54 | N/A | N/A |
| Profit Margin (TTM) | 0.00% | 22.49% | Morgan Stanley |
| Operating Margin (TTM) | -52.03% | 34.12% | Morgan Stanley |
| EBITDA Margin (TTM) | N/A | 34.12% | N/A |
| Return on Equity | -88.66% | 14.13% | Morgan Stanley |
| Return on Assets (TTM) | -9.21% | 1.16% | Morgan Stanley |
| Free Cash Flow (TTM) | $-3.43M | $-2.10B | FTAC Emerald |
| Dividend Yield | N/A | 2.15% | N/A |
| 1-Year Return | -64.56% | 41.40% | Morgan Stanley |
| Price-to-Sales Ratio (TTM) | 33.15 | 3.52 | Morgan Stanley |
| Enterprise Value | $245.52M | $158.15B | Morgan Stanley |
| EV/Revenue Ratio | 47.27 | 2.41 | Morgan Stanley |
| Gross Profit Margin (TTM) | 53.28% | N/A | N/A |
| Revenue per Share (TTM) | $0 | $41 | Morgan Stanley |
| Earnings per Share (Diluted) | $-0.73 | $8.83 | Morgan Stanley |
| Beta (Stock Volatility) | 0.16 | 1.32 | FTAC Emerald |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
FTAC Emerald vs Morgan Stanley Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| FTAC Emerald | -4.13% | -5.84% | -10.62% | -6.52% | -64.50% | -65.57% |
| Morgan Stanley | 0.03% | -2.19% | 2.56% | 10.11% | 2.40% | 15.46% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| FTAC Emerald | -64.56% | -64.79% | -64.79% | 330.00% | 287.00% | 287.00% |
| Morgan Stanley | 41.40% | 65.96% | 172.40% | 323.11% | 475.59% | 179.42% |
Performance & Financial Health Analysis: FTAC Emerald vs Morgan Stanley
| Metric | FLD | MS |
|---|---|---|
| Market Information | ||
| Market Cap | $172.19M | $231.12B |
| Market Cap Category | Micro cap | Mega cap |
| 10 Day Avg. Volume | 154,350 | 4,617,060 |
| 90 Day Avg. Volume | 184,720 | 5,290,947 |
| Last Close | $3.71 | $144.11 |
| 52 Week Range | $2.51 - $14.00 | $94.09 - $149.08 |
| % from 52W High | -73.50% | -3.33% |
| All-Time High | $14.00 (Feb 17, 2025) | $148.81 (Aug 15, 2025) |
| % from All-Time High | -73.50% | -3.16% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.62% | 0.11% |
| Quarterly Earnings Growth | 0.59% | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | 0.22% |
| Operating Margin (TTM) | -0.52% | 0.34% |
| Return on Equity (TTM) | -0.89% | 0.14% |
| Debt to Equity (MRQ) | 90.30 | 438.54 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.90 | $61.59 |
| Cash per Share (MRQ) | $0.14 | $352.68 |
| Operating Cash Flow (TTM) | $-11,170,795 | $-17,670,000,640 |
| Levered Free Cash Flow (TTM) | $-5,771,365 | $12.80B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 2.15% |
| Last 12-Month Dividend | N/A | $2.79 |
Valuation & Enterprise Metrics Analysis: FTAC Emerald vs Morgan Stanley
| Metric | FLD | MS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 218.80 | 16.40 |
| Forward P/E | -9.80 | 18.26 |
| PEG Ratio | -0.14 | 1.01 |
| Price to Sales (TTM) | 33.15 | 3.52 |
| Price to Book (MRQ) | 1.94 | 2.35 |
| Market Capitalization | ||
| Market Capitalization | $172.19M | $231.12B |
| Enterprise Value | $245.52M | $158.15B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 47.27 | 2.41 |
| Enterprise to EBITDA | -13.54 | N/A |
| Risk & Other Metrics | ||
| Beta | 0.16 | 1.32 |
| Book Value per Share (MRQ) | $1.90 | $61.59 |
Financial Statements Comparison: FTAC Emerald vs Morgan Stanley
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | FLD | MS |
|---|---|---|
| Revenue/Sales | $7.09M | $16.52B |
| Cost of Goods Sold | $6.50M | N/A |
| Gross Profit | $584,112 | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-9.50M | N/A |
| EBITDA | $-31.90M | N/A |
| Pre-Tax Income | $-48.88M | $5.54B |
| Income Tax | $3,978 | $1.17B |
| Net Income (Profit) | $-48.88M | $4.37B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | FLD | MS |
|---|---|---|
| Cash & Equivalents | $11.70M | $60.84B |
| Total Current Assets | $24.42M | N/A |
| Total Current Liabilities | $11.11M | N/A |
| Long-Term Debt | $65.09M | $303.93B |
| Total Shareholders Equity | $71.88M | $107.85B |
| Retained Earnings | $-150.23M | $107.65B |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | FLD | MS |
|---|---|---|
| Operating Cash Flow | $-26.80M | $-67.29B |
| Capital Expenditures | N/A | $-713.00M |
| Free Cash Flow | $-5.22M | $-24.69B |
| Debt Repayment | N/A | $-20.85B |
| Common Stock Repurchase | N/A | $-2.03B |
Short Interest & Institutional Ownership Analysis
| Metric | FLD | MS |
|---|---|---|
| Shares Short | 194,523 | 14.60M |
| Short Ratio | 0.91 | 2.55 |
| Short % of Float | 0.01% | 0.01% |
| Average Daily Volume (10 Day) | 154,350 | 4,617,060 |
| Average Daily Volume (90 Day) | 184,720 | 5,290,947 |
| Shares Outstanding | 46.14M | 1.61B |
| Float Shares | 3.89M | 1.21B |
| % Held by Insiders | 0.70% | 0.24% |
| % Held by Institutions | 0.23% | 0.63% |
Dividend Analysis & Yield Comparison: FTAC Emerald vs Morgan Stanley
| Metric | FLD | MS |
|---|---|---|
| Last 12-Month Dividend | N/A | $2.79 |
| Last 12-Month Dividend Yield | N/A | 2.15% |
| 3-Year Avg Annual Dividend | N/A | $3.10 |
| 3-Year Avg Dividend Yield | N/A | 0.90% |
| 3-Year Total Dividends | N/A | $9.31 |
| Ex-Dividend Date | N/A | Jan 31, 2025 |